Practice of endoscopy during COVID-19 pandemic: position statements of the Asian Pacific Society for Digestive Endoscopy (APSDE-COVID statements)
Philip Wai Yan Chiu(Chinese University of Hong Kong), Francis K.L. Chan(Chinese University of Hong Kong), Siew C. Ng(Chinese University of Hong Kong), Dong Wan Seo(Dankook University), Rungsun Rerknimitr(Chulalongkorn University), D. Nageshwar Reddy(Kalasalingam Academy of Research and Education), Haruhiro Inoue(Center for Digestive and Liver Diseases), Khean‐Lee Goh(University of Malaya), Han‐Mo Chiu(National Taiwan University), Joo Young Cho(CHA University Bundang Medical Center), Lawrence KY Ho(National University Hospital), En-Qiang Ling Hu(Chinese PLA General Hospital), Seigo Kitano(Japanese Foundation For Cancer Research), Hisao Tajiri(Jikei University School of Medicine), David G. Hewett, Hsiu-Po Wang(National Taiwan University Hospital), Shiaw Hooi Ho(University of Malaya)
Cited by 332
Related Papers
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations
|Nature Genetics|2015|2.8k
ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use
|Circulation|2008|845
Screening for gastric cancer in Asia: current evidence and practice
|The Lancet Oncology|2008|830
Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry
|Gastroenterology|2020|692
World Gastroenterology Organisation Global Guideline
|Journal of Clinical Gastroenterology|2011|539